Damae Medical Announces its deepLiveTM Device has Received 510(k) Clearance from the FDA, Marking a Major Milestone in Company's U.S. Market Expansion Plans PARIS, ÎLE-DE-FRANCE, FRANCE, March 4, 2025 ...
PARIS – Damae Medical SAS has just raised nearly $6 million to develop new technology to detect skin cancer noninvasively without need for a biopsy. This series A round was led by BNP Paribas ...
Anais Barut, cofounder and CEO of DAMAE Medical, is going after cancer with a new medical imaging device. The technology is aimed to better detect skin cancer with in depth cellular images.
Damae Medical Announces its deepLive™ Device has Received 510(k) Clearance from the FDA, Marking a Major Milestone in Company’s U.S. Market Expansion Plans PARIS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results